Pulmonary Embolism: A Frequent Occurrence in Indian Patients with Symptomatic Lower Limb Venous Thrombosis  by Parakh, Rajiv et al.
86 ASIAN JOURNAL OF SURGERY  VOL 29 • NO 2 • APRIL 2006
070/2001
Original Article
© 2006 Elsevier. All rights reserved.
Introduction
Pulmonary embolism (PE) is the most severe complication
of deep venous thrombosis (DVT). Both conditions produce
few specific symptoms and signs, hence, clinical diagnosis is
unreliable.1 The manifestation spectrum of PE ranges from
silent to a massive, sometimes suddenly fatal, event. Prompt
diagnosis and appropriate treatment of this condition can
dramatically reduce its attendant mortality and morbidity.
Pulmonary Embolism: A Frequent Occurrence in
Indian Patients with Symptomatic Lower Limb
Venous Thrombosis
In patients with DVT, a clinical dilemma arises because
a large number of patients with PE do not present with the
classical symptoms and signs. The need for anticoagulation
necessitates objective testing to confirm or exclude these diag-
noses. It has been proven previously that proximal venous
thrombosis is associated with a high prevalence of PE.2–4
PE carries a significant risk of mortality. Nearly 10% of
patients who die of PE do so within 1 hour of the onset of
symptoms.5 The few population-based studies have demon-
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strated an average annual incidence of DVT and PE of 48 and
23 per 100,000 persons, respectively.6,7
The detection of silent PE in patients with DVT is of prime
importance, especially when outpatient treatment is con-
sidered.8,9 Ventilation-perfusion lung scanning is a highly
sensitive, noninvasive method to detect PE.10,11 The accuracy
is further improved by combining perfusion scanning with
clinical assessment. Based on the hypothesis that DVT and
PE are separate but related components of a larger syndrome
(venous thromboembolism, VTE), we performed radionuclide
venography and ventilation-perfusion lung scanning in all
consecutive patients with clinically suspected DVT to deter-
mine the prevalence of PE.
Patients and methods
Patients
Between January 2001 and July 2004, consecutive in- and out-
patients presenting with clinically suspected lower limb
DVT were enrolled in the study. Patients were eligible if they
were aged 18 years or older. A combination radionuclide
ascending venography with lung perfusion scan was performed
within 24 hours of presentation at the Department of Nuclear
Medicine.
Radionuclide venography
Radionuclide venography was performed following slow in-
fusion of 4–6 mCi of 99m technetium (Tc)-labelled albumin
macroaggregates into the dorsal pedal veins of both feet.
Tourniquets were applied tightly bilaterally at three levels
(above ankle, below knee and at mid thigh). The transit of
tracer was assessed simultaneously in the anterior and poste-
rior projections. Dynamic whole-body imaging was con-
ducted with a dual-head variable-geometry gamma camera,
using a high-resolution parallel-hole collimator.
Perfusion scan
A lung perfusion scan was performed immediately after
radionuclide venography. A minimum of four views (anterior,
posterior, and right and left lateral oblique) were acquired
on a 256 × 256 matrix, using a parallel-hole high-resolution
collimator with a minimum of 500,000 counts.
Ventilation scan
A ventilation scan was obtained if there was any abnormal-
ity on the lung perfusion scan. The patient was nebulized
using 99m Tc-labelled diethylenetriaminepentaacetic acid
aerosol immediately before lung images were obtained using
a parallel-hole high-resolution collimator with a minimum of
200,000 counts. At least four views were acquired.
Interpretation of radionuclide venography
Two independent experienced nuclear medicine physicians
analysed the images. The following criteria were used to diag-
nose DVT:12 no or poor visualization of a vein, visualization
of collateral veins, visualization of superficial veins in the
absence of deep veins and pre-obstruction accumulation of
tracer (pooling).
Interpretation of radionuclide lung scans
The lung perfusion and ventilation scans were evaluated
using the Prospective Investigation of PE Diagnosis (PIOPED)
criteria.10 Scan defects were classified into high, intermediate
or low probability of PE or normal scan.
Results
A total of 1,552 consecutive in- and outpatients (618 males,
934 females; mean age, 42 years; age range, 24–65 years) with
clinically suspected lower limb DVT were enrolled in the study.
Most patients (1,314; 84.7%) presented on an outpatient basis.
Swelling of the lower limbs was the most common pre-
senting symptom of DVT (Table 1). Many patients presented
with a combination of symptoms. Additional symptoms
suggestive of PE, such as breathlessness, chest discomfort,
chest pain and haemoptysis, were found in only 251 (16.2%)
patients. Haemodynamic instability (systolic blood pressure
< 100 mmHg, poor peripheral tissue perfusion) was evident in
28 (1.8%) patients.
Of the 1,552 patients, 744 had DVT detected by radio-
nuclide venography, 183 (24.6%) in both lower limbs. Many
Table 1. Presenting symptoms in patients with suspected deep
venous thrombosis (DVT)
Symptom n
Pain in lower limb 603
Swelling of lower limb 1,328
Swelling and pain 518
Breathlessness 103
Chest tightness/discomfort 94
Chest pain 42
Haemoptysis 12
Hypotension 28
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(70%) had proximal (suprapopliteal) DVT, which was sub-
divided into infrainguinal (femoropopliteal) or suprain-
guinal (iliofemoral) DVT. Among patients with radionuclide
venography-proven DVT, a high-probability lung scan was
noted in 294 (39.5%) (Table 2). In contrast, in patients with-
out radionuclide detectable DVT, the prevalence of a high-
probability lung scan was 4.5% (p < 0.001, chi-square).
The prevalence of lung scan defects in patients with or
without symptoms suggestive of PE is shown in Table 3.
Nearly half of patients with a high-probability lung scan had
no symptoms suggestive of PE.
Table 4 shows the distribution of lung scan defects accord-
ing to the site of DVT. A higher prevalence of PE was noted in
patients with suprapopliteal DVT than those with popliteal
vein thrombosis. The overall prevalence of PE in patients with
DVT was 39.5%. The PE prevalence in patients with popliteal,
infrainguinal and suprainguinal DVT was 23%, 42% and 52%,
respectively.
The mortality rate in patients with DVT was 0.95% (6
patients with a high-probability scan and 1 with an intermedi-
ate-probability scan).
Discussion
PE and DVT are separate but related aspects of the same dyna-
mic disease process, now termed VTE.13,14 An increasing vol-
ume of Western literature has confirmed that PE occurs fre-
quently in patients with DVT.2–4,15,16 However, literature from
Asia has shown a wide variation in the incidence of DVT and
VTE. In their systematic review, Liew et al suggested that, in
spite of the variation in the reported occurrence of VTE, this
disease is not as rare in Asia as was thought previously.17 The
common occurrence of DVT in Asian patients has also been
reported in other hospital-based studies.18,19 However, a re-
cent population-based study by Cheuk et al noted that VTE
is not as common in Chinese as in Caucasians.20
Table 3. Prevalence of lung scan defects in patients
Patients with DVT Patients with no DVT
Lung scan defects
Low probability 18 (7)0 45 (6)0
Intermediate probability 127 (48)0 26 (10)
High probability 294 (158) 36 (22)
The numbers in parentheses denote the numbers of patients with symptoms suggestive of pulmonary embolism. DVT = deep venous
thrombosis.
Table 2. Results of radionuclide lung scan
Patients with proven DVT Patients with no DVT
V/Q scan result
Normal 305 (42%).0 701 (86.8%)
Low probability 18 (1.5%) 45 (5.5%)
Intermediate probability 127 (17%)0. 26 (3.2%)
High probability 294 (39.5%) 36 (4.5%)
V/Q = ventilation/perfusion; DVT = deep venous thrombosis.
Table 4. Correlation between site of deep venous thrombosis (DVT) and lung scan defects
n Intermediate probability High probability
Site of DVT
Popliteal 223 016 054 (23%)
Suprapopliteal 521 111 240 (46%)
Infrainguinal 314 065 132 (42%)
Suprainguinal 207 046 108 (52%)
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Our hospital-based data confirm that PE is indeed a fre-
quent condition in patients with symptomatic lower limb
DVT. The rationale for using combination radionuclide as-
cending venography and lung perfusion scan was the simul-
taneous assessment of both peripheral (venous) and pulmo-
nary thromboembolism. Reports assessing the accuracy of
radionuclide venography have shown that it compares well
with contrast venography, especially for popliteal and
suprapopliteal DVT.12,21 The sensitivity and specificity in
the infrapopliteal segment, however, is slightly lower.21 In
the current duplex era, this single test gives accurate, reliable
and operator independent information.
The prevalence of high-probability lung scans in patients
with DVT was nearly 40% in our study, which is similar to the
reports of other investigators who used scintigraphy or an-
giography to document PE.2–4,15 Table 5 compares the pre-
valence of PE in previously published reports and the present
study. Considering that in patients with a non-high proba-
bility scan, pulmonary angiography can confirm emboli in
approximately 30%,22 the true prevalence of PE may be higher.
Clinical symptoms suggestive of PE were noted in 158 (53%)
patients with DVT with a high-probability lung scan. Thus,
approximately half of patients had a silent PE documented on
lung perfusion scan.
Detection of silent PE in patients with DVT has important
implications, especially when outpatient treatment is con-
sidered. Home-administered low-molecular-weight heparin
(LMWH) and subcutaneous heparin are as efficacious as intra-
venous unfractionated heparin administered in hospital.23
Considering the benefits in terms of avoidance of hospital stay
and no need for monitoring, we advocate the home-based
use of LMWH followed by oral anticoagulation for patients
with DVT. Patients with DVT and no evidence of PE were safely
managed on an outpatient basis and treated with LMWH.
Those with high- and intermediate-probability lung scans
were admitted and their treatment protocol is outlined in
Figures 1 and 2.
The other advantage of obtaining a baseline lung scan
in patients with DVT is that it serves as a comparison when
a repeat scan is performed on later suspicion of PE. Hence,
Figure 1. Management protocol for patients with
radionuclide venography-detected deep venous
thrombosis (DVT). LMWH = low-molecular-weight
heparin; RV = right ventricular; PE = pulmonary
embolism; IVC = inferior vena cava.
Table 5. Reported prevalence of pulmonary embolism (PE) in patients with deep venous thrombosis (DVT)
Authors Diagnostic modality DVT, n PE, n (% prevalence)
Huisman et al2 Venography, V/Q scan 089 45 (51%)
Moser et al3 Venography, pulmonary angiography 044 23 (52%)
Meignan et al4 Venography, V/Q scan 622 .309 (49.5%)
Monreal et al15 Venography, V/Q scan 116 29 (25%)
Borst-Krafek et al16 Duplex, V/Q scan 212 (42–51%)*
Present study Radionuclide venography with V/Q scan 744 294 (39.5% overall) (23–52%)*
*Site-specific prevalence (popliteal, suprapopliteal or suprainguinal DVT). V/Q = ventilation/perfusion.
ThrombolysisIVC filterAnticoagulation
Haemodynamic instability
RV hypokinesia
Pulmonary hypertension
Extensive DVT with phlegmasia
PE despite adequate
anticoagulation
Admission
Monitoring
Echocardiography
Thrombophilia screen
Discharge on LMWH
DVT detected
Lung perfusion scans
Intermediate probabilityNormal/low probability High probability
Haemodynamically stable
Good RV function
No pulmonary hypertension
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Figure 2. Treatment protocol for patients with no
deep venous thrombosis (DVT) on radionuclide
venography. AC = anticoagulation; CT = computed
tomography; PE = pulmonary embolism.
AdmissionDischarge without AC
PENo PE
Repeat duplex at 1 week
Admission
CT pulmonary angiography
D-dimer
Discharge without AC
Lung perfusion scans
Intermediate probabilityNormal/low probability High probability
perfusion defects detected before initiation of treatment would
not be interpreted later as therapeutic failure. Fresh lung scan
defects in a patient on adequate anticoagulation may be an
indication for inferior vena cava filter placement.
The detection of PE at such a high frequency should not
produce a dramatic change in management. Evidence has
shown no major benefit of thrombolytic therapy over stan-
dard anticoagulation therapy in terms of mortality, recurrent
PE or chronic complications.24 Hence, thrombolysis is used
only in situations where it is truly indicated.24,25 The absolute
indication for thrombolysis is massive PE with haemody-
namic instability. Evidence of right ventricular hypokinesia or
raised pulmonary artery systolic pressure (> 50 mmHg) are
also considered to be relative indications for thrombolysis in
haemodynamically stable patients. Extensive DVT, especially
with phlegmasia alba or dolens, may also be managed using
thrombolytic therapy to achieve more complete clot lysis.
LMWH is as safe and effective as unfractionated heparin
and can be used in carefully selected patients with clinically
stable PE.26 However, we prefer to hospitalize patients with
PE and monitor them for a few days during anticoagulation
therapy.
In conclusion, our study reveals a high prevalence of PE
in Indian patients presenting with symptomatic lower limb
DVT. These findings confirm the need for increased aware-
ness of VTE in Asian populations. This high prevalence com-
pares well with the previously reported rate of PE in Western
patients with DVT. Further studies are needed to determine
the cost-effectiveness of such single diagnostic tools for the
diagnosis of both DVT and PE.
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